| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 6, no: 4 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005635 | nuclear envelope | 4 | 2 |
| GO:0005783 | endoplasmic reticulum | 5 | 2 |
| GO:0008303 | caspase complex | 5 | 11 |
| GO:0031967 | organelle envelope | 3 | 2 |
| GO:0031975 | envelope | 2 | 2 |
| GO:0032991 | protein-containing complex | 1 | 11 |
| GO:0042765 | GPI-anchor transamidase complex | 3 | 11 |
| GO:0043226 | organelle | 2 | 2 |
| GO:0043227 | membrane-bounded organelle | 3 | 2 |
| GO:0043229 | intracellular organelle | 3 | 2 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
| GO:0098796 | membrane protein complex | 2 | 11 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
| GO:0140534 | endoplasmic reticulum protein-containing complex | 2 | 11 |
| GO:1902494 | catalytic complex | 2 | 11 |
| GO:1905368 | peptidase complex | 3 | 11 |
| GO:1905369 | endopeptidase complex | 4 | 11 |
Related structures:
AlphaFold database: Q4QE06
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006508 | proteolysis | 4 | 11 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
| GO:0008104 | protein localization | 4 | 2 |
| GO:0008152 | metabolic process | 1 | 11 |
| GO:0009987 | cellular process | 1 | 2 |
| GO:0016255 | attachment of GPI anchor to protein | 5 | 11 |
| GO:0019538 | protein metabolic process | 3 | 11 |
| GO:0033036 | macromolecule localization | 2 | 2 |
| GO:0034394 | protein localization to cell surface | 5 | 2 |
| GO:0036211 | protein modification process | 4 | 11 |
| GO:0043170 | macromolecule metabolic process | 3 | 11 |
| GO:0043412 | macromolecule modification | 4 | 11 |
| GO:0044238 | primary metabolic process | 2 | 11 |
| GO:0051179 | localization | 1 | 2 |
| GO:0051641 | cellular localization | 2 | 2 |
| GO:0070727 | cellular macromolecule localization | 3 | 2 |
| GO:0071704 | organic substance metabolic process | 2 | 11 |
| GO:1901564 | organonitrogen compound metabolic process | 3 | 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 11 |
| GO:0003923 | GPI-anchor transamidase activity | 6 | 11 |
| GO:0004175 | endopeptidase activity | 4 | 11 |
| GO:0004197 | cysteine-type endopeptidase activity | 5 | 11 |
| GO:0008233 | peptidase activity | 3 | 11 |
| GO:0008234 | cysteine-type peptidase activity | 4 | 11 |
| GO:0016787 | hydrolase activity | 2 | 11 |
| GO:0140096 | catalytic activity, acting on a protein | 2 | 11 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 147 | 149 | PF00675 | 0.425 |
| CLV_NRD_NRD_1 | 165 | 167 | PF00675 | 0.412 |
| CLV_NRD_NRD_1 | 212 | 214 | PF00675 | 0.413 |
| CLV_NRD_NRD_1 | 286 | 288 | PF00675 | 0.627 |
| CLV_PCSK_KEX2_1 | 147 | 149 | PF00082 | 0.425 |
| CLV_PCSK_KEX2_1 | 165 | 167 | PF00082 | 0.412 |
| CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.425 |
| CLV_PCSK_KEX2_1 | 286 | 288 | PF00082 | 0.624 |
| CLV_PCSK_SKI1_1 | 147 | 151 | PF00082 | 0.425 |
| CLV_PCSK_SKI1_1 | 165 | 169 | PF00082 | 0.523 |
| CLV_PCSK_SKI1_1 | 216 | 220 | PF00082 | 0.425 |
| CLV_PCSK_SKI1_1 | 64 | 68 | PF00082 | 0.425 |
| DEG_APCC_DBOX_1 | 146 | 154 | PF00400 | 0.225 |
| DOC_CYCLIN_RxL_1 | 162 | 171 | PF00134 | 0.307 |
| DOC_MAPK_gen_1 | 212 | 219 | PF00069 | 0.212 |
| DOC_MAPK_MEF2A_6 | 172 | 179 | PF00069 | 0.211 |
| DOC_PP1_RVXF_1 | 214 | 220 | PF00149 | 0.227 |
| DOC_PP4_FxxP_1 | 113 | 116 | PF00568 | 0.293 |
| DOC_USP7_MATH_1 | 39 | 43 | PF00917 | 0.443 |
| DOC_USP7_MATH_2 | 109 | 115 | PF00917 | 0.227 |
| DOC_USP7_UBL2_3 | 185 | 189 | PF12436 | 0.307 |
| DOC_WW_Pin1_4 | 158 | 163 | PF00397 | 0.225 |
| LIG_14-3-3_CanoR_1 | 147 | 153 | PF00244 | 0.307 |
| LIG_14-3-3_CanoR_1 | 165 | 175 | PF00244 | 0.243 |
| LIG_14-3-3_CanoR_1 | 6 | 15 | PF00244 | 0.427 |
| LIG_14-3-3_CanoR_1 | 70 | 78 | PF00244 | 0.212 |
| LIG_BRCT_BRCA1_1 | 22 | 26 | PF00533 | 0.391 |
| LIG_BRCT_BRCA1_1 | 96 | 100 | PF00533 | 0.307 |
| LIG_deltaCOP1_diTrp_1 | 333 | 339 | PF00928 | 0.308 |
| LIG_FHA_1 | 162 | 168 | PF00498 | 0.307 |
| LIG_FHA_1 | 191 | 197 | PF00498 | 0.305 |
| LIG_FHA_1 | 259 | 265 | PF00498 | 0.227 |
| LIG_FHA_1 | 283 | 289 | PF00498 | 0.418 |
| LIG_FHA_1 | 8 | 14 | PF00498 | 0.319 |
| LIG_LIR_Apic_2 | 111 | 116 | PF02991 | 0.251 |
| LIG_LIR_Gen_1 | 28 | 38 | PF02991 | 0.386 |
| LIG_LIR_Gen_1 | 53 | 60 | PF02991 | 0.211 |
| LIG_LIR_Gen_1 | 77 | 87 | PF02991 | 0.307 |
| LIG_LIR_LC3C_4 | 10 | 15 | PF02991 | 0.246 |
| LIG_LIR_Nem_3 | 186 | 190 | PF02991 | 0.224 |
| LIG_LIR_Nem_3 | 270 | 275 | PF02991 | 0.286 |
| LIG_LIR_Nem_3 | 28 | 33 | PF02991 | 0.358 |
| LIG_LIR_Nem_3 | 299 | 303 | PF02991 | 0.239 |
| LIG_LIR_Nem_3 | 53 | 59 | PF02991 | 0.233 |
| LIG_LIR_Nem_3 | 77 | 82 | PF02991 | 0.277 |
| LIG_SH2_CRK | 214 | 218 | PF00017 | 0.225 |
| LIG_SH2_CRK | 272 | 276 | PF00017 | 0.272 |
| LIG_SH2_CRK | 30 | 34 | PF00017 | 0.440 |
| LIG_SH2_CRK | 79 | 83 | PF00017 | 0.307 |
| LIG_SH2_STAP1 | 251 | 255 | PF00017 | 0.243 |
| LIG_SH2_STAT3 | 251 | 254 | PF00017 | 0.293 |
| LIG_SH2_STAT3 | 255 | 258 | PF00017 | 0.293 |
| LIG_SH2_STAT5 | 178 | 181 | PF00017 | 0.250 |
| LIG_SH2_STAT5 | 187 | 190 | PF00017 | 0.252 |
| LIG_SH2_STAT5 | 65 | 68 | PF00017 | 0.225 |
| LIG_SH3_3 | 230 | 236 | PF00018 | 0.258 |
| LIG_SH3_3 | 322 | 328 | PF00018 | 0.290 |
| LIG_Sin3_3 | 9 | 16 | PF02671 | 0.233 |
| LIG_SUMO_SIM_anti_2 | 10 | 16 | PF11976 | 0.374 |
| LIG_SUMO_SIM_anti_2 | 291 | 297 | PF11976 | 0.356 |
| LIG_SUMO_SIM_par_1 | 16 | 21 | PF11976 | 0.228 |
| LIG_WRC_WIRS_1 | 263 | 268 | PF05994 | 0.246 |
| MOD_CDC14_SPxK_1 | 3 | 6 | PF00782 | 0.542 |
| MOD_CDK_SPxxK_3 | 158 | 165 | PF00069 | 0.225 |
| MOD_CK1_1 | 199 | 205 | PF00069 | 0.258 |
| MOD_CK2_1 | 241 | 247 | PF00069 | 0.270 |
| MOD_GlcNHglycan | 133 | 136 | PF01048 | 0.490 |
| MOD_GlcNHglycan | 41 | 44 | PF01048 | 0.673 |
| MOD_GSK3_1 | 166 | 173 | PF00069 | 0.218 |
| MOD_GSK3_1 | 190 | 197 | PF00069 | 0.226 |
| MOD_GSK3_1 | 241 | 248 | PF00069 | 0.292 |
| MOD_GSK3_1 | 258 | 265 | PF00069 | 0.292 |
| MOD_GSK3_1 | 278 | 285 | PF00069 | 0.227 |
| MOD_GSK3_1 | 310 | 317 | PF00069 | 0.427 |
| MOD_N-GLC_1 | 275 | 280 | PF02516 | 0.535 |
| MOD_N-GLC_1 | 314 | 319 | PF02516 | 0.604 |
| MOD_NEK2_1 | 18 | 23 | PF00069 | 0.358 |
| MOD_NEK2_1 | 220 | 225 | PF00069 | 0.242 |
| MOD_NEK2_1 | 275 | 280 | PF00069 | 0.310 |
| MOD_NEK2_1 | 296 | 301 | PF00069 | 0.250 |
| MOD_NEK2_1 | 7 | 12 | PF00069 | 0.337 |
| MOD_NEK2_1 | 96 | 101 | PF00069 | 0.272 |
| MOD_PIKK_1 | 111 | 117 | PF00454 | 0.247 |
| MOD_PK_1 | 148 | 154 | PF00069 | 0.307 |
| MOD_PKA_2 | 5 | 11 | PF00069 | 0.432 |
| MOD_PKA_2 | 69 | 75 | PF00069 | 0.212 |
| MOD_Plk_4 | 148 | 154 | PF00069 | 0.295 |
| MOD_Plk_4 | 183 | 189 | PF00069 | 0.244 |
| MOD_Plk_4 | 201 | 207 | PF00069 | 0.138 |
| MOD_Plk_4 | 262 | 268 | PF00069 | 0.259 |
| MOD_Plk_4 | 270 | 276 | PF00069 | 0.263 |
| MOD_Plk_4 | 291 | 297 | PF00069 | 0.323 |
| MOD_Plk_4 | 74 | 80 | PF00069 | 0.258 |
| MOD_ProDKin_1 | 158 | 164 | PF00069 | 0.225 |
| MOD_SUMO_rev_2 | 169 | 173 | PF00179 | 0.211 |
| TRG_DiLeu_BaEn_1 | 270 | 275 | PF01217 | 0.249 |
| TRG_DiLeu_BaLyEn_6 | 163 | 168 | PF01217 | 0.307 |
| TRG_ENDOCYTIC_2 | 187 | 190 | PF00928 | 0.338 |
| TRG_ENDOCYTIC_2 | 214 | 217 | PF00928 | 0.258 |
| TRG_ENDOCYTIC_2 | 272 | 275 | PF00928 | 0.299 |
| TRG_ENDOCYTIC_2 | 30 | 33 | PF00928 | 0.436 |
| TRG_ENDOCYTIC_2 | 79 | 82 | PF00928 | 0.312 |
| TRG_ER_diArg_1 | 146 | 148 | PF00400 | 0.225 |
| TRG_ER_diArg_1 | 165 | 167 | PF00400 | 0.212 |
| TRG_ER_diArg_1 | 212 | 214 | PF00400 | 0.225 |
| TRG_ER_diArg_1 | 286 | 288 | PF00400 | 0.356 |
| TRG_NES_CRM1_1 | 258 | 270 | PF08389 | 0.224 |
| TRG_Pf-PMV_PEXEL_1 | 165 | 170 | PF00026 | 0.412 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1IJ31 | Leptomonas seymouri | 80% | 98% |
| A0A1X0P6S3 | Trypanosomatidae | 54% | 100% |
| A0A3S5H727 | Leishmania donovani | 91% | 100% |
| A4H9E0 | Leishmania braziliensis | 80% | 100% |
| A4HXR1 | Leishmania infantum | 91% | 100% |
| B6DTF5 | Bodo saltans | 39% | 100% |
| D0A043 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 100% |
| E9ARH3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
| O89017 | Mus musculus | 27% | 82% |
| P49044 | Vicia sativa | 24% | 72% |
| Q8T4E1 | Drosophila melanogaster | 33% | 100% |
| Q95M12 | Bos taurus | 27% | 82% |
| Q99538 | Homo sapiens | 27% | 82% |
| Q9LJX8 | Arabidopsis thaliana | 26% | 77% |
| Q9USP5 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 36% | 94% |
| V5BWA3 | Trypanosoma cruzi | 55% | 100% |